These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 2889204)
1. [Factors in sudden and non-sudden death after myocardial infarction]. Lascault G; Fillette F; Grosgogeat Y Presse Med; 1987 Sep; 16(31):1533-7. PubMed ID: 2889204 [TBL] [Abstract][Full Text] [Related]
2. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction]. Arós Borau F; Loma-Osorio A; Torres Bosco A Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518 [TBL] [Abstract][Full Text] [Related]
3. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders]. Mösslacher H Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091 [TBL] [Abstract][Full Text] [Related]
4. [Betablockers, anti-arrhythmia and anti-ischemia agents and other drugs ... in the follow-up of myocardial infarction]. Coumel P Arch Mal Coeur Vaiss; 1990 Sep; 83(10):1497-9. PubMed ID: 1978650 [No Abstract] [Full Text] [Related]
5. When is drug therapy warranted to prevent sudden cardiac death? Singh BN Drugs; 1991; 41 Suppl 2():24-46. PubMed ID: 1711967 [TBL] [Abstract][Full Text] [Related]
6. [Can sudden death be prevented by drugs?]. Amann FW Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1142-8. PubMed ID: 1699258 [TBL] [Abstract][Full Text] [Related]
7. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects]. Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348 [TBL] [Abstract][Full Text] [Related]
8. Overview of completed sudden death trials: US experience. Furberg CD Cardiology; 1987; 74 Suppl 2():24-31. PubMed ID: 2887288 [TBL] [Abstract][Full Text] [Related]
10. [Sudden death in heart failure. Analysis and prevention]. Aumont MC; Cohen-Solal A; Himbert D; Steg PG; Paillole C Presse Med; 1992 Jan 4-11; 21(1):33-8. PubMed ID: 1346553 [TBL] [Abstract][Full Text] [Related]
11. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists? Stevenson WG; Ridker PM JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557 [TBL] [Abstract][Full Text] [Related]
12. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
13. Cardiac death prevention in post-myocardial infarction patients: a review. Boissel JP; Leizorovicz A; Faucomprez C Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625 [No Abstract] [Full Text] [Related]
14. [Sudden death of cardiac origin]. Lekieffre J Presse Med; 1987 Sep; 16(29):1424-9. PubMed ID: 2958799 [TBL] [Abstract][Full Text] [Related]
15. [Arrhythmias in chronic heart failure. Prognostic significance and treatment]. Koenig A; Chauvin M; Thévenin D; Brechenmacher C Presse Med; 1991 May; 20(20):950-5. PubMed ID: 1676164 [TBL] [Abstract][Full Text] [Related]
16. Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction. Lewis WR Clin Cardiol; 1997 Nov; 20(11):910. PubMed ID: 9383581 [No Abstract] [Full Text] [Related]